Review





Similar Products

99
ATCC cancer cell lines mcf 7
Cancer Cell Lines Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcf/MCF7/pmc13752813-372-1-19
Average 99 stars, based on 1 article reviews
cancer cell lines mcf 7 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

mcf 7  (ATCC)
99
ATCC mcf 7
SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines <t>(MCF-7</t> and SK-BR-3), and the normal mammary epithelial cell line MCF-10A. Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.
Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcf/MCF7/pmc13771711-87-0-2
Average 99 stars, based on 1 article reviews
mcf 7 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC mcf 10a
SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines (MCF-7 and SK-BR-3), and the normal mammary epithelial cell line <t>MCF-10A.</t> Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.
Mcf 10a, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcf/MCF+10A/pmc13771711-92-0-2
Average 99 stars, based on 1 article reviews
mcf 10a - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC hcoepic cells
SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines (MCF-7 and SK-BR-3), and the normal mammary epithelial cell line <t>MCF-10A.</t> Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.
Hcoepic Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcf/MCF+10A/pm42995200-50-16-22
Average 99 stars, based on 1 article reviews
hcoepic cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

mcf10a  (ATCC)
99
ATCC mcf10a
SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines (MCF-7 and SK-BR-3), and the normal mammary epithelial cell line <t>MCF-10A.</t> Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.
Mcf10a, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcf/MCF+10A/pmc13757685-138-0-14
Average 99 stars, based on 1 article reviews
mcf10a - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC mcf 7 cells
SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines (MCF-7 and SK-BR-3), and the normal mammary epithelial cell line <t>MCF-10A.</t> Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.
Mcf 7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcf/MCF7/pm42994513-60-0-10
Average 99 stars, based on 1 article reviews
mcf 7 cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC mcf 7 breast cancer cells
RT-PCR of ESR1 transcripts in <t>MCF-7</t> (left) and TAMR1 (right) cells seeded at high density and treated for 24 h with 0, 0.25, 0.5, 1, 2.5 or 5 mM metformin, with a DNA size marker between the panels. Arrowheads mark the full-length ERα product and the ERα46 product. Below, the full-length share, full-length / (full-length + ERα46), obtained by densitometry of the gel shown with local background subtracted from each lane. Single experiment; no statistical comparison is made. These values were measured from the gel image for this report because the original quantification could not be located, and are provided as a source-data file.
Mcf 7 Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcf/MCF7/bio_rxiv__64898__2026__11__04__764423-23-0-4
Average 99 stars, based on 1 article reviews
mcf 7 breast cancer cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC normal human breast epithelium mcf10a cells
RT-PCR of ESR1 transcripts in <t>MCF-7</t> (left) and TAMR1 (right) cells seeded at high density and treated for 24 h with 0, 0.25, 0.5, 1, 2.5 or 5 mM metformin, with a DNA size marker between the panels. Arrowheads mark the full-length ERα product and the ERα46 product. Below, the full-length share, full-length / (full-length + ERα46), obtained by densitometry of the gel shown with local background subtracted from each lane. Single experiment; no statistical comparison is made. These values were measured from the gel image for this report because the original quantification could not be located, and are provided as a source-data file.
Normal Human Breast Epithelium Mcf10a Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mcf/MCF+10A/pm42986876-78-1-7
Average 99 stars, based on 1 article reviews
normal human breast epithelium mcf10a cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines (MCF-7 and SK-BR-3), and the normal mammary epithelial cell line MCF-10A. Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.

Journal: iScience

Article Title: Targeting SOST-LRRC15 axis impairs triple-negative breast cancer progression by regulating WNT signaling and EMT

doi: 10.1016/j.isci.2026.118212

Figure Lengend Snippet: SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines (MCF-7 and SK-BR-3), and the normal mammary epithelial cell line MCF-10A. Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.

Article Snippet: MCF-7 , American Type Culture Collection , Cat# HTB-22; RRID:CVCL_0031.

Techniques: Marker, Expressing, Quantitative RT-PCR, Analysis, Western Blot, Control

Journal: iScience

Article Title: Targeting SOST-LRRC15 axis impairs triple-negative breast cancer progression by regulating WNT signaling and EMT

doi: 10.1016/j.isci.2026.118212

Figure Lengend Snippet:

Article Snippet: MCF-7 , American Type Culture Collection , Cat# HTB-22; RRID:CVCL_0031.

Techniques:

SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines (MCF-7 and SK-BR-3), and the normal mammary epithelial cell line MCF-10A. Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.

Journal: iScience

Article Title: Targeting SOST-LRRC15 axis impairs triple-negative breast cancer progression by regulating WNT signaling and EMT

doi: 10.1016/j.isci.2026.118212

Figure Lengend Snippet: SOST is a marker of poor prognosis highly expressed in triple-negative breast cancer (A) SOST mRNA expression levels in triple-negative breast cancer (TNBC) samples versus normal tissues from the TCGA-BRCA dataset. ⁎ p < 0.05, by Student’s t test. (B) RT-qPCR analysis of SOST mRNA expression in the TNBC cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-436), the non-TNBC cell lines (MCF-7 and SK-BR-3), and the normal mammary epithelial cell line MCF-10A. Data are shown as mean ± SD of three independent experiments ( n = 3). ⁎ p < 0.05, ⁎⁎ p < 0.01, ⁎⁎⁎ p < 0.001, by the Student’s t test. (C) Western blot analysis of SOST protein levels in the indicated cell lines. GAPDH was used as a loading control. The blot shown is representative of three independent experiments. (D) Kaplan-Meier overall survival curves for patients in the TCGA-BRCA cohort stratified by high (red) versus low (blue) SOST expression. p value from log rank test. (E and F) Correlation analyses between SOST expression and EMT-transcription factors TGFB1 (E) and ZEB1 (F) in TNBC samples from the TCGA-BRCA cohort. Pearson correlation coefficients (r) and p values are indicated.

Article Snippet: MCF-10A , American Type Culture Collection , Cat# CRL-10317; RRID:CVCL_0598.

Techniques: Marker, Expressing, Quantitative RT-PCR, Analysis, Western Blot, Control

Journal: iScience

Article Title: Targeting SOST-LRRC15 axis impairs triple-negative breast cancer progression by regulating WNT signaling and EMT

doi: 10.1016/j.isci.2026.118212

Figure Lengend Snippet:

Article Snippet: MCF-10A , American Type Culture Collection , Cat# CRL-10317; RRID:CVCL_0598.

Techniques:

RT-PCR of ESR1 transcripts in MCF-7 (left) and TAMR1 (right) cells seeded at high density and treated for 24 h with 0, 0.25, 0.5, 1, 2.5 or 5 mM metformin, with a DNA size marker between the panels. Arrowheads mark the full-length ERα product and the ERα46 product. Below, the full-length share, full-length / (full-length + ERα46), obtained by densitometry of the gel shown with local background subtracted from each lane. Single experiment; no statistical comparison is made. These values were measured from the gel image for this report because the original quantification could not be located, and are provided as a source-data file.

Journal: bioRxiv

Article Title: Metformin lowers HMGA1a and RBM3 protein in breast cancer cells, and its effect on ESR1 splicing depends on cell density and exposure time

doi: 10.64898/2026.11.04.764423

Figure Lengend Snippet: RT-PCR of ESR1 transcripts in MCF-7 (left) and TAMR1 (right) cells seeded at high density and treated for 24 h with 0, 0.25, 0.5, 1, 2.5 or 5 mM metformin, with a DNA size marker between the panels. Arrowheads mark the full-length ERα product and the ERα46 product. Below, the full-length share, full-length / (full-length + ERα46), obtained by densitometry of the gel shown with local background subtracted from each lane. Single experiment; no statistical comparison is made. These values were measured from the gel image for this report because the original quantification could not be located, and are provided as a source-data file.

Article Snippet: MCF-7 breast cancer cells (ATCC HTB-22) were cultured in DMEM (Nacalai Tesque, 08456-65) with 10% EquaFETAL (Atlas Biologicals, EF-0500-A), non-essential amino acids and penicillin-streptomycin.

Techniques: Reverse Transcription Polymerase Chain Reaction, Marker, Comparison

Immunoblots of MCF-7 and TAMR1 cell lysates after 24 h of treatment with 0, 2.5 or 5 mM metformin at two seeding densities (10 4 and 10 5 cells), probed for HMGA1a, and of TAMR1 lysates at 24 and 48 h probed for RBM3, with ACTB as loading control. The four HMGA1a panels are regions of one membrane and the ACTB panels come from four separate images; uncropped membranes are provided as Supplementary Figure S1. Single experiment.

Journal: bioRxiv

Article Title: Metformin lowers HMGA1a and RBM3 protein in breast cancer cells, and its effect on ESR1 splicing depends on cell density and exposure time

doi: 10.64898/2026.11.04.764423

Figure Lengend Snippet: Immunoblots of MCF-7 and TAMR1 cell lysates after 24 h of treatment with 0, 2.5 or 5 mM metformin at two seeding densities (10 4 and 10 5 cells), probed for HMGA1a, and of TAMR1 lysates at 24 and 48 h probed for RBM3, with ACTB as loading control. The four HMGA1a panels are regions of one membrane and the ACTB panels come from four separate images; uncropped membranes are provided as Supplementary Figure S1. Single experiment.

Article Snippet: MCF-7 breast cancer cells (ATCC HTB-22) were cultured in DMEM (Nacalai Tesque, 08456-65) with 10% EquaFETAL (Atlas Biologicals, EF-0500-A), non-essential amino acids and penicillin-streptomycin.

Techniques: Western Blot, Control, Membrane

RT-PCR for full-length ESR1 , ERα46 and ACTB on RNA extracted from the MCF-7 (left) and TAMR1 (right) xenograft tumours of the earlier study , grouped by treatment: vehicle (−), tamoxifen (TAM), metformin (MET) or both. The ESR1 and ACTB panels of each group are separate gels and are separated by a horizontal rule. Within each treatment group, each lane is one tumour. The mice carried an MCF-7 tumour and a TAMR1 tumour on opposite flanks and were identified by ear mark, but the source records do not state which animal and which flank each lane came from, so the lanes cannot be matched to individual tumours or paired between the two panels. Lanes in which amplification failed are shown as obtained.

Journal: bioRxiv

Article Title: Metformin lowers HMGA1a and RBM3 protein in breast cancer cells, and its effect on ESR1 splicing depends on cell density and exposure time

doi: 10.64898/2026.11.04.764423

Figure Lengend Snippet: RT-PCR for full-length ESR1 , ERα46 and ACTB on RNA extracted from the MCF-7 (left) and TAMR1 (right) xenograft tumours of the earlier study , grouped by treatment: vehicle (−), tamoxifen (TAM), metformin (MET) or both. The ESR1 and ACTB panels of each group are separate gels and are separated by a horizontal rule. Within each treatment group, each lane is one tumour. The mice carried an MCF-7 tumour and a TAMR1 tumour on opposite flanks and were identified by ear mark, but the source records do not state which animal and which flank each lane came from, so the lanes cannot be matched to individual tumours or paired between the two panels. Lanes in which amplification failed are shown as obtained.

Article Snippet: MCF-7 breast cancer cells (ATCC HTB-22) were cultured in DMEM (Nacalai Tesque, 08456-65) with 10% EquaFETAL (Atlas Biologicals, EF-0500-A), non-essential amino acids and penicillin-streptomycin.

Techniques: Reverse Transcription Polymerase Chain Reaction, Xenograft Assay, Amplification